DOCSLIB.ORG

2012-2013) of the Aichi Cancer Center Research Institute

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2012-2013) of the Aichi Cancer Center Research Institute Aichi Cancer Center Research Institute Scientific Report 2012 – 2013 Chikusa-ku, Nagoya 464-8681 Japan (The Cover) The Aichi Cancer Center Research Institute Main Building Published by Dr. Taira Kinoshita President Aichi Cancer Center Research Institute 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan Telephone: 052-762-6111 Facsimile: 052-763-5233 Editorial Committee Dr. Masahiro Aoki (Division of Molecular Pathology) Dr. Keiichiro Sakuma (Division of Molecular Pathology) Dr. Hiroshi Kumimoto (Central Service Unit) Dr. Malcolm A. Moore, English Editor Ms. Hiromi Tamaki (Director's Office) Printed by Nagoya University COOP 1 Furoucho, Chikusa-ku, Nagoya 464-0814, Japan Contents Preface Taira Kinoshita 1 Organization of the Aichi Cancer Center Research Institute 2 Scientific Reports Division of Epidemiology and Prevention General Summary 5 1. Descriptive epidemiology 1.1. Differences in incidence and trends of hematologic malignancies in Japan and the United States Chihara, D., Ito, H., Matsuda, M., Shibata, A., Katsumi, A., Nakamura, S., Sobue, T.,Morton, LM., Weisenburger, DD., and Matsuo, K. 2. The hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC) study 2.1. Time to first cigarette and upper aerodigestive tract cancer risk in Japan Matsuo, K., Gallus, S., Negri, E., Kawakita, D., Oze, I., Hosono, S., Ito, H., Hatooka, S., Hasegawa, Y., Shinoda, M., Tajima, K., La Vecchia, C., and Tanaka, H. 2.2. Time to first cigarette and lung cancer risk in Japan Ito, H., Gallus, S., Hosono, S., Oze, I., Fukumoto, K., Yatabe, Y., Hida, T., Mitsudomi, T., Negri, E., Yokoi, K., Tajima, K., La Vecchia, C., Tanaka H., and Matsuo K. 2.3. Polymorphisms in base excision repair genes are associated with endometrial cancer risk among postmenopausal Japanese women Hosono, S., Matsuo, K., Ito, H., Hirose, K., Oze, I., Watanabe, M., Nakanishi, T., Tajima, K., and Tanaka, H. 2.4. Coffee and green tea consumption is associated with upper aerodigestive tract cancer in Japan Oze, I., Matsuo, K., Kawakita, D., Hosono, S., Ito, H., Watanabe, M., Hatooka, S., Hasegawa, Y., Shinoda, M., Tajima, K., and Tanaka, H. 3. Tobacco control 3.1. Factors associated with increasing body weight after smoking cessation therapy in Japan Tanaka, H., Taniguchi, C., Oze, I., Saka, H., Ito, H., Tachibana, K., Tokoro, A., Nozaki, Y., Nakamichi, N., Suzuki, Y., and Suehisa, H. 3.2. Cigarette smoke inhalation and lung cancer risk: Case-control study in Japan Fukumoto, K., Ito, H., Park C., Tanaka, H., Matsuo, K., Tajima, K., and Takezaki, T. Division of Oncological Pathology General Summary 1. Peptide-based non-invasive molecular delivery system by developing novel cancer cell-penetrating peptides (tumor-homing CPPs) for advanced medical i applications Saito, K., Matsushita, M., and Kondo, E 2. Coxsackie and adenovirus receptor – a novel negative regulator of RhoA associated kinase (ROCK) - is a critical regulator of survival and growth of oral squamous carcinoma cells Saito, K., Sakaguchi, M., Iioka, H., Matsui, M., Nakanishi, H., Huh N., and Kondo, E. 3. Anti-tumor impact of p14ARF on gefitinib-resistant non-small cell lung cancers Saito, K., Takigawa, N., Ohtani, N., Iioka, H., Tomita, Y., Ueda, R., Fukuoka, J., Kuwahara, K., Ichihara, E., Kiura, K., and Kondo, E. 4. Lapatinib sensitivities of two novel trastuzumab-resistant HER2 gene-amplified gastric cancer cell lines Oshima, Y., Tanaka, H., Murakami, H., Ito, Y., Furuya, T., Kondo, E., Kodera, Y., and Nakanishi H. 5. LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells Nakata, S., Campos, B., Bageritz, J., Bermejo, JL., Becker, N., Engel, F., Acker, T., Momma, S., Herold-Mende, C., Lichter, P., Radlwimmer, B., and Goidts, V. Division of Molecular Oncology General Summary 1. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via the Hippo signaling cascade Tanaka, I., Osada, H., Fujii, M., Fukatsu, A., Hida, T., Horio, Y., Kondo, Y., Sato, A., Hasegawa, Y., Tsujimura, T., and Y Sekido 2. RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer Fukatsu, A., Ishiguro, F., Tanaka, I., Kudo, T., Nakagawa, K., Shinjo, K., Kondo, Y., Fujii, M., Hasegawa, Y., Tomizawa, K., Mitsudomi, T., Osada, H., Hata, Y., Sekido, Y. Division of Molecular Medicine General Summary 1. Cell cycle deregulation contributes to acute transformation in chronic type adult T-cell leukemia/lymphoma Yoshida, N., Karube, K., Utsunomiya, A., Tsukasaki, K., Imaizumi, Y., Taira, N., Uike, N., Umino, A., Arita, K., Katayama, M., Tsuzuki, S., Kinoshita, T., Ohshima, K., and Seto, M. 2. Generation of mouse models of lymphoid neoplasms using retroviral gene transduction of in vitro-induced germinal center B and T cells Arita, K., Maeda-Kasugai, Y., Ohshima, K., Tsuzuki, S., Katayama, M., Karube, K., Yoshida, N., Sugiyama, T., and Seto, M. 3. Comprehensive gene expression profiles of NK cell neoplasms indicate vorinostat as an effective drug candidate Karube, K., Tsuzuki, S., Yoshida, N., Arita, K., Kato, H., Katayama, M., Ko, YH., Ohshima, K., Nakamura, S., Kinoshita, T., and Seto, M. 4. Clonal heterogeneity of lymphoid malignancies is related to poor prognosis ii Katayama, M., Tagawa, H., Nakagawa, M., Fukuhara, N., Sivasundaram, S., Takeuchi, I. , Kasugai, Y., Arita, K., Yoshida, N., Kakiuchi, T., Karube, K., Tsuzuki. S, Nakamura, S., and Seto, M. 5. TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice Tsuzuki, S., and Seto, M. Division of Immunology General Summary 1. Constitutively active autophagy causes a CTL epitope generation in pancreatic cancer cells Demachi-Okamura, A., and Kuzushima, K. 2. Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H Akatsuka, Y., Inaguma, Y., Akahori, Y., Murayama, Y., Shiraishi, K., Endoh, A., Demachi-Okamura, A., Hiramatsu, K., Nishimura, Y., Takahashi, To., Emi, N., and Kuzushima, K. 3. Pluripotent stem cell-derived proliferating myeloid cells as a possible basis for cellular vaccine cancer immunotherapy Zhang, R., Liu, T., Maki, H., Kuzushima, K., and Uemura, Y. 4. Modification of IL-12p70/osteopontin balance in dendritic cells by ligand activation of invariant NKT cells Zhang, R., Liu, T., Kuzushima, K., and Uemura, Y. Division of Virology General Summary 1. Interaction between Basic Residues of Epstein-Barr Virus EBNA1 Protein and Cellular Chromatin Mediates Viral Plasmid Maintenance Kanda, T. and Tsurumi, T. 2. Contribution of Myocyte Enhancer Factor 2 (MEF2) Family Transcription Factors to BZLF1 Expression in Epstein-Barr virus Reactivation from Latency Murata, T. and Tsurumi, T. 3. Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma cells Murata, T. and Tsurumi, T. 4. Different Distributions of Epstein-Barr Virus Early and Late Gene Transcripts within Viral Replication Compartments Sugimoto, A., Sato, Y., Murata, T., Kanda, T., and Tsurumi, T. 5. Nuclear Transport of Epstein-Barr Virus DNA Polymerase is Dependent on the BMRF1 Polymerase Processivity Factor and Molecular Chaperone Hsp90 Kawashima, D., Murata, T., Kanda, T., and Tsurumi T. 6. Epstein-Barr Virus Deubiquitinase Downregulates TRAF6-mediated NF-κB Signaling during Productive Replication Saito, S., Murata, T., Kanda, T., and Tsurumi, T. iii 7. Pin1 Interacts with the Epstein-Barr Virus DNA Polymerase Catalytic Subunit and Regulates Viral DNA Replication Narita, Y., Murata, T., Kanda, T., and Tsurumi, T. 8. HLA-restricted Presentation of WT1 Tumor Antigen in B-lymphoblastoid Cell Lines Established using a Maxi-EBV System Kanda, T., Kuzushima, K., and Tsurumi, T. 9. Epigenetic Histone Modification of the Epstein-Barr Virus BZLF1 Promoter during Latency and Reactivation in Raji Cells Murata, T., Kondo, Y., and Tsurumi, T. Division of Molecular Pathology General Summary 1. c-Myc and CDX2 mediate E-selectin ligand glycan expression in colon cancer cells undergoing EMT Sakuma, K., Kannagi, R., and Aoki, M. 2. CDX Transcription Factors Positively Regulate Expression of PLEKHG1 in Intestinal Epithelium Aoki, M., Fujishita, T., and Taketo, MM. 3. Roles of the mTOR signaling in intestinal adenocarcinoma formation in cis-Apc/Smad4 mutant mice Fujishita, T., Taketo, MM., and Aoki, M. Division of Biochemistry General Summary 1. Emerging roles of ubiquitin-proteasome machinery in formation of primary cilia Kasahara, K., Era, S., Kawamoto, E., Kawakami, Y., Kiyono, T., Kawamura, Y., Goshima, N., and Inagaki, M. 2. Cytokinetic failure induces aneuploidy and aging in vimentin phosphorylation deficient mice Tanaka, Hir., Matsuyama, M., Inoko, A., Goto, H., Yonemura, S., Kobori, K., Tanigawa, N., Hayashi, Y., Kondo, E., Itohara, S., Izawa, I. and Inagaki, M. 3. Perspective of Aurora A kinase as a therapeutic target for cancer Goto, H., Watanabe, N., Kobori, K., Inoko, A., Mochizuki, H., Togashi, T., Kisu, Y., Kawamura, Y., Kawakami, Y., Goshima, N., and Inagaki, M. 4. Novel cell cycle regulation through centrosomes Inoko, A., Inaba, H., He, D., Goto, H., Hayashi, Y., Izawa, I., Urano, T., Yonemura, S., Kiyono, T., Goshima, N., and Inagaki, M. 5. Interaction of Cell Polarity Regulator Scribble with Multidrug Resistance Protein 4 (MRP4/ABCC4) Izawa, I., Hayashi, Y., and Inagaki, M. Division of Epigenomics General Summary 1. The PRC2
Load more

Recommended publications
  • LIST of the WOOD PACKAGING MATERIAL PRODUCER for EXPORT 2007/2/10 Registration Number Registered Facility Address Phone
    LIST OF THE WOOD PACKAGING MATERIAL PRODUCER FOR EXPORT 2007/2/10 Registration number Registered Facility Address Phone ０００１００２ ITOS CORPORATION KAMOME-JIGYOSHO 62-1 KAMOME-CHO NAKA-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045-622-1421 ASAGAMI CORPORATION YOKOHAMA BRANCH YAMASHITA ０００１００４ 279-10 YAMASHITA-CHO NAKA-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045-651-2196 OFFICE ０００１００７ SEITARO ARAI & CO., LTD. TORIHAMA WAREHOUSE 12-57 TORIHAMA-CHO KANAZAWA-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045-774-6600 ０００１００８ ISHIKAWA CO., LTD. YOKOHAMA FACTORY 18-24 DAIKOKU-CHO TSURUMI-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045-521-6171 ０００１０１０ ISHIWATA SHOTEN CO., LTD. 4-13-2 MATSUKAGE-CHO NAKA-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045-641-5626 THE IZUMI EXPRESS CO., LTD. TOKYO BRANCH, PACKING ０００１０１１ 8 DAIKOKU-FUTO TSURUMI-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045-504-9431 CENTER C/O KOUEI-SAGYO HONMOKUEIGYOUSHO, 3-1 HONMOKU-FUTO NAKA-KU ０００１０１２ INAGAKI CO., LTD. HONMOKU B-2 CFS 045-260-1160 YOKOHAMA-SHI KANAGAWA, JAPAN ０００１０１３ INOUE MOKUZAI CO., LTD. 895-3 SYAKE EBINA-SHI KANAGAWA, JAPAN 046-236-6512 ０００１０１５ UTOC CORPORATION T-1 OFFICE 15 DAIKOKU-FUTO TSURUMI-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045-501-8379 ０００１０１６ UTOC CORPORATION HONMOKU B-1 OFFICE B-1, HONMOKU-FUTOU, NAKA-KU, YOKOHAMA-SHI, KANAGAWA, JAPAN 045-621-5781 ０００１０１７ UTOC CORPORATION HONMOKU D-5 CFS 1-16, HONMOKU-FUTOU, NAKA-KU, YOKOHAMA-SHI, KANAGAWA, JAPAN 045-623-1241 ０００１０１８ UTOC CORPORATION HONMOKU B-3 OFFICE B-3, HONMOKU-FUTOU, NAKA-KU, YOKOHAMA-SHI, KANAGAWA, JAPAN 045-621-6226 ０００１０２０ A.B. SHOUKAI CO., LTD.
    [Show full text]
  • Osaka University Knowledge Archive : OUKA
    Title MEMOIRS of the Institute of Scientific and Industrial Research, Osaka University Volume 75 Author(s) MEMOIRS of the Institute of Scientific and Citation Industrial Research, Osaka University. 75 P.1- P.216 Issue Date 2018 Text Version publisher URL http://hdl.handle.net/11094/77455 DOI rights Note Osaka University Knowledge Archive : OUKA https://ir.library.osaka-u.ac.jp/ Osaka University Contents Foreword ··················································································· 1 Outline of ISIR 1. Research Activities ········································································· 2 2. Education ···················································································· 20 3. International Exchange ···································································· 21 4. Concluding Remarks ······································································· 23 Activities of Divisions Division of Information and Quantum Sciences ·········································· 27 Division of Advanced Materials and Beam Science ······································ 43 Division of Biological and Molecular Sciences ··········································· 59 Division of Next Industry Generation ······················································· 73 Division of Special Projects ·································································· 77 Division of Joint Research ···································································· 79 Activities of Centers Nanoscience Nanotechnology Center
    [Show full text]
  • Supplementary Online Content
    Supplementary Online Content Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial. JAMA. doi:10.1001/jama.2014.15690 eMethods. Additional Statistical Methodology, Members of the Steering Committee, Data Monitoring Committee, Event Adjudication Committee, and Locations and Names of Study Investigators eTable 1. Compliance with Aspirin Treatment and Use of Prohibited Concomitant Medications (Antiplatelet or Anticoagulant Agents) This supplementary material has been provided by the authors to give readers additional information about their work. © 2014 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/26/2021 eMethods Additional Statistical Methodology The following rules were applied for the minimization method to balance for age a sex in each randomization stratum: (1) The minimization score was calculated based on sum of ‘the number of allocated patients in each factor’ for each of the two study groups. If the difference in score between the two groups was not more than 3, then simple randomization was used. (2) If the difference was more than 3, then allocation probability is switched from 0.5 to 0.9 (i.e. biased coin allocation). (3) If the number of allocated patients according to rule 2 was very different (difference > 99), then the next patient was allocated to be balanced (4). If the number of allocated patients according rule 3 in each group at a specific site is very different (difference > 5), then the next patient was allocated to be balanced.
    [Show full text]
  • En Cerebrovascular Disease1 the Role of Cnm Positive Streptococcus
    19 O-01 Oral Session 01 En May 19（Wed）16：30 ～ 18：00 Room 04（ICC Kyoto 2F Room A） Cerebrovascular disease1 Chairs：‌‌Yoshiaki‌Itoh Osaka‌City‌University‌Graduate‌School‌of‌Medicine Free ‌Kenichi‌Todo Department‌of‌Neurology,‌Osaka‌University‌Graduate‌School‌of‌Medicine ‌ Papers O-01-1 The role of Cnm positive Streptococcus mutans in the pathogenesis of intracerebral hemorrhage Shuichi Tonomura ‌ (Oral) Department of Neurology, Graduate School of Medicine, Kyoto University, Japan ／Department of Neurology, National Cerebral and Cardiovascular Center, Japan ／Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Japan O-01-2 Low dihomo-gamma-linolenic acid is associated with an unfavorable outcome in cardioembolism Takeo Sato Department of Neurology, the Jikei University School of Medicine, Japan - 96 - O-01-3 Association of recurrent stroke subtype with medication type of 19 secondary prevention in ESUS Taizen Nakase Stroke Comprehensive Medical Center, Akita University Hospital, Japan O-01-4 The impact and risk factors of anemia following acute ischemic stroke therapy Makiko Tanaka Department of Stroke Medicine, JCHO Hoshigaoka Medical Center, Japan O-01-5 The role of occludin in Tight Junction in Blood Brain Barrier after stroke Shintaro Sugiyama Department of Neurology, Graduate School of Medicine, Osaka University, Japan O-01-6 Examination of regulation of expression of nAChR by TMEM35 after Free cerebral ischemia ‌ Tsutomu Sasaki Papers Department of Neurology, Graduate School of Medicine,
    [Show full text]
  • Bacterial Sheet-Powered Rotation of a Micro-Object
    G Model SNB-18802; No. of Pages 6 ARTICLE IN PRESS Sensors and Actuators B xxx (2015) xxx–xxx Contents lists available at ScienceDirect Sensors and Actuators B: Chemical jo urnal homepage: www.elsevier.com/locate/snb Bacterial sheet-powered rotation of a micro-object a,∗ a b f Masaru Kojima , Tatsuya Miyamoto , Masahiro Nakajima , Michio Homma , g c,d,e Tatsuo Arai , Toshio Fukuda a Department of Micro-Nano Systems Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan b Center for Micro-Nano Mechatronics, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan c Institute for Advanced Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan d Faculty of Science and Engineering, Meijo University, 1-501, Shiogamaguchi, Tenpaku-ku, Nagoya 468-8502, Japan e Intelligent Robotics Institute, School of Mechatronic Engineering, Beijing Institute of Technology, 5 South Zhongguancun Street, Haidian District, Beijing, 100081, China f Department of Biological Science, Graduate School of Science, Nagoya University, Furo-cho, Chikusa-Ku, Nagoya 464-8602, Japan g Division of Systems Science, Department of Systems Innovation, Graduate School of Engineering Science, Osaka University, 1-3, Machikaneyama-cho, Toyonaka 560-8531, Japan a r t i c l e i n f o a b s t r a c t Article history: Recently, there have been numerous reports of the use of microbes as bio-actuators. In particular, bacteria Received 23 February 2015 are one of the promising candidates for bioactuator development, because of which they have garnered Received in revised form 11 July 2015 a lot of interest lately.
    [Show full text]
  • Organizational Changes
    March 19, 2012 SMBC Nikko Securities Inc. Organizational Changes SMBC Nikko Securities Inc. today announces organizational changes as follows. 1. Organizational Changes (Effective as of March 19, 2012) (1) Human Resources Recruiting Division (Abolition) The business of Recruiting Division are transferred to Human Resources Division. (2) Administrative Operation Compensation & Benefit Planning Division (Transfer) Compensation & Benefit Planning Division is transferred from Compensation & Benefit Planning. (3) Financial Markets Fixed Income Trading Division (Reorganized) Fixed Income Trading Division is reorganized as Fixed Income Trading I Division and Fixed Income Trading II Division. Derivatives Division (Transfer) Derivatives Division is placed under sole management from joint management with Equity. (4) Research Financial Market & Economic Research Division (Change of Name) Financial Market Research Division is renamed Financial Market & Economic Research Division. Global Investment Strategy Division (Abolition) The businesses of Global Investment Strategy are transferred to Equity Research Division and Financial Market & Economic Research Division. (5) Mergers and Acquisitions Mergers and Acquisitions V Division (Abolition) The businesses of Mergers and Acquisitions V Division are transferred to Mergers and Acquisitions I - III Division. Mergers and Acquisitions Solutions (Change of name) Mergers and Acquisitions VI Division is renamed Mergers and Acquisitions Solutions Division. (6) Corporate Planning Business Research Division (Abolition) The businesses of Business Research Division are transferred to Management Planning & Administration Division. This material is an English translation of Japanese announcement made on March 19 2012. Although the company intended to faithfully translate the Japanese document into English, the accuracy and correctness of this translation are not guaranteed and thus you are encouraged to refer to the original Japanese document.
    [Show full text]
  • Program May 14 (Thursday) Presidential Lecturepresidential
    Plenary Program May 14 (Thursday) Presidential Lecture 16:20-17:05 Plenary Lecture 01 Room: National Convention Hall Chairperson: Teruo Kawada (Kyoto University, Japan) PL01 Leptin and the Regulation of Food Intake and Body Weight Jeffrey M. Friedman Rockefeller University, USA Educational 17:05-17:50 Plenary Lecture 02 Room: National Convention Hall Chairperson: Tohru Fushiki (Ryukoku University, Japan) PL02 Functional Food Science in Japan: Present State and Perspectives Keiko Abe Symposium The University of Tokyo, Japan, the Kanagawa Academy of Science & Technology (KAST), Japan May 15 (Friday) 9:00-9:45 Plenary Lecture 03 Room: Main Hall at Conference Center (Satellite Viewing is available in Room 301-304) Sponsored Symposium Chairperson: Chizuru Nishida (World Health Organization (WHO), Switzerland) PL03 The Present Role of Industrial Food Processing in Food Systems and Its Implications for Controlling the Obesity Pandemic Carlos A. Monteiro University of São Paulo, Brazil May 16 (Saturday) Luncheon 9:00-9:45 Plenary Lecture 04 Room: Main Hall at Conference Center (Satellite Viewing is available in Room 301-304) Chairperson: Pek-Yee Chow (Federation of Asian Nutrition Societies, Singapore Nutrition and Dietetics Association (SNDA), Singapore) PL04 Multi-Stakeholders and Multi-Strategic Approaches for Food and Nutrition Security Evening Kraisid Tontisirin Mahidol University, Thailand May 17 (Sunday) FANS Report FANS 9:00-9:45 Plenary Lecture 05 Room: Main Hall at Conference Center (Satellite Viewing is available in Room 301-304) Chairperson:
    [Show full text]
  • PDF Document, 5,8 MB
    Company Name Country Meeting Date Meeting Type Item Number Proposal Vote Instruction UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1a Elect Director William C. Ballard, Jr. For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1b Elect Director Richard T. Burke For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1c Elect Director Timothy P. Flynn For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1d Elect Director Stephen J. Hemsley For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1e Elect Director Michele J. Hooper For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1f Elect Director F. William McNabb, III For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1g Elect Director Valerie C. Montgomery Rice For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1h Elect Director John H. Noseworthy For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1i Elect Director Glenn M. Renwick For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1j Elect Director David S. Wichmann For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 1k Elect Director Gail R. Wilensky For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 2 Advisory Vote to Ratify Named Executive Officers' Compensation Against UnitedHealth Group Incorporated USA 03-Jun-19 Annual 3 Ratify Deloitte & Touche LLP as Auditors For UnitedHealth Group Incorporated USA 03-Jun-19 Annual 4 Amend Proxy Access Right For Alliance Data Systems Corporation USA 04-Jun-19 Annual 1.1 Elect Director Bruce K. Anderson For Alliance Data Systems Corporation USA 04-Jun-19 Annual 1.2 Elect Director Roger H.
    [Show full text]
  • Naoki Sato, Kuniya Asai, Ryo Munakata, Toshiyuki
    Appendices Study investigators (53 hospitals): Nippon Medical School: Naoki Sato, Kuniya Asai, Ryo Munakata, Toshiyuki Aokage, Asuka Yoshida; Tokyo Women’s Medical University: Yuichiro Minami, Dai Yumino, Masayuki Mizuno, Erisa Kawada, Kentaro Yoshida, Yuri Ozaki, Tomohito Kogure, Shintaro Haruki; Saitamaken Saiseikai Kurihashi Hospital: Masayuki Mizuno; Aoyama Hospital, Tokyo Women’s Medical University: Katsuya Kajimoto; Saiseikai Kumamoto Hospital: Koichi Nakao, Tadashi Sawamura, Toshiaki Nuki; Toyota Memorial Hospital: Ryoji Ishiki, Shigeki Yokota; Tokushima Prefectural Central Hospital: Hiroyuki Fujinaga, Takashi Yamamoto, Kenji Harada, Akihiro Saito, Norihito Kageyama, Takanobu Okumura; Chiba Hokusoh Hospital, Nippon Medical School: Noritake Hata, Koji Murai, Ayaka Nozaki; Shizuoka Medical Center: Hidekazu Kawanaka, Jun Tanabe; Hyogo Prefectural Amagasaki Hospital: Yukihito Sato; Oji General Hospital: Katsuhisa Ishii, Hitoshi Oiwa, Tomoaki Matsumoto, Daisuke Yoshida, Nobuo Kato; Showa University Fujigaoka Hospital: Hiroshi Suzuki, Nobuyuki Shimizu; Edogawa Hospital: Takehiko Keida, Masaki Fujita, Kentaro Nakamura, Toshiya Chinen, Kentaro Meguro, Tatsuro Kikuchi, Toshiyuki Nishikido, Marohito Nakata, Tatsuya Yamashita, Masaya Nakata; Kurashiki Central Hospital: Akitoshi Hirono, Kazuaki Mitsudo, Kazushige Kadota, Noriko Makita, Nagisa Watanabe; Hyogo College of Medicine: Masaaki Kawabata, Kenichi Fujii; Yamaguchi University: Shinichi Okuda, Shigeki Kobayashi; Fukui Cardiovascular Center: Ikuo Moriuchi, Kiyo-o Mizuno, Kazuo Osato, Tatsuaki
    [Show full text]
  • Investigating the Influence of Edo and Meiji Period Monster Art on Contemporary Japanese Visual Media
    1 Investigating the Influence of Edo and Meiji Period Monster Art on Contemporary Japanese Visual Media Zília Papp A thesis submitted to the University of New South Wales in fulfillment of the requirements for the degree of Doctor of Philosophy 2008 2 Acknowledgements I would like to thank my academic supervisors Doctor William Armour, Senior Lecturer, School of Languages and Linguistics, and Professor Julian MurpIIhet, School of English, Media, and Performing Arts at the University of New South Wales. I would like to thank the kind help and academic advice of my external advisory supervisor, Professor John Clark, CIHA, FAHA, Director of the Australian Centre for Asian Art and Archeology and Professor of Asian Art History at the Department of Art History and Film Studies, the University of Sydney. I am very grateful for the kind advice I received from Doctor Alan Cholodenko, Honorary Associate, Department of Art History and Film Studies, the University of Sydney. I am also very grateful for the advice and help I received from animation director and cultural historian Jankovics Marcell, DLA, Hungarian Academy of Fine Arts, Director of Pannonia Filmstudio 1996-2007. Additionally, I would like to convey my gratitude for the kind help of the curatorial staff at the Mizuki Shigeru Memorial Museum in Sakaiminato city, Tottori prefecture; the Fukuoka Asian Art Museum; of Doctor Kawanabe Kusumi, MD, D.Msc, Director of the Kawanabe Kyôsai Memorial Museum and Timothy Clark, Head of Japanese Section, Department of Asia, the British Museum. I would also like to convey my gratitude for the generous help I received from the filming crews of the 2005 film Yôkai Daisensô and 2007 film Gegegeno Kitaro.
    [Show full text]
  • Religion and Psychotherapy in Modern Japan
    Downloaded by [New York University] at 02:00 07 August 2016 This is an outstanding book . the first high-quality academic work on religion and the psy disciplines in modern Japan. It covers the topics of modern religion and psychotherapy in Japan and connects them with the recent major crises of Aum Shinrikyo and the earthquake and tsunami of March 2011. Akihito Suzuki, Professor of History at Keio University, Japan Chris Harding and his fellow editors have brought together a significant set of essays examining the relationship between the ‘psy disciplines’ of psychiatry, psychology, and psychotherapy, and religion in Japan. Hard- ing’s overview takes us beyond the problematic definitional issues relating to religion to show how the ‘psy disciplines’ have helped shape the ways in which religion is manifested in modern Japan. The essays that follow intro- duce a wealth of Japanese scholarship in the field that will be of value to all who are interested in religion, psychotherapy, and Japanese culture in general. Ian Reader, Professor of Religious Studies at Lancaster University, UK A novel take on the role of religion in Japan, and another significant con- tribution to understanding religion in modern Japanese society. Instead of the usual image of Buddhist meditation as zazen, we find fascinating studies of various kinds of mental and psychological care, from naikan meditation to Morita therapy. These chapters show how modern psychotherapy and traditional religion are both utilized (though not always harmoniously) for dealing with ‘spiritual’ issues. This collection presents work by many of the best religious studies scholars in Japan today.
    [Show full text]
  • Thermec'2018 Conference Program
    THERMEC’2018 International Conference on PROCESSING & MANUFACTURING OF ADVANCED MATERIALS Processing, Fabrication, Properties, Applications July 9-13, 2018 Paris, FRANCE CONFERENCE PROGRAM IMPORTANT REQUEST TO THERMEC‘2018 PARTICIPANTS THERMEC LUNCHEON GROUP A, B and C & TIMINGS FOR EACH GROUP The dining hall ( au LOFT, where luncheon on Monday, Tuesday, Wednesday & Thursday ) at this venue has maximum sitting capacity of 550 persons. Due to safety reasons, it is important that not more than 550 persons take luncheon at a time. We request your cooperation in this matter. LUNCHEON TIMES FOR GROUPS ARE: GROUP-A (Last Names : A to H ) 12h00 to 12h40 GROUP-B (Last Names : I to P ) 12h40 to 13h20 GROUP-C (Last names : Q to Z ) 13h20 to 14h00 We would appreciate if you please observe above arrangement in order to avoid overcrowding in the dining hall & area THERMEC’2018 INTERNATIONAL CONFERENCE on PROCESSING & MANUFACTURING OF ADVANCED MATERIALS July 09- 13, 2018 Cité des Sciences et de l’industrie, 30 Avenue Corentin Cariou, 75019 Paris, France CONFERENCE PROGRAM Intl’ Conf. on Processing & Manufacturing of Advanced Materials July 9 – 13, 2018, Paris, France Contents General Information ……………………………………………………………………………………….…...1 Acknowledgements …………………………………………………………………………………… ……….6 Inaugural Session ……………………………………………………………………………………. ……….14 Sessions Matrix…………………………………………………………………………………………………15 Session A – Room : Louis Armand Est SESSION A1 : Advanced Steels & TMP Micro-alloyed Steels 1…………………………………………........17 SESSION A2 : Advanced Steels
    [Show full text]